rexmd wegovy semaglutide digital health company Diabetes advocacy group discourages use of compounded GLP-1 drugs Wegovy (Semaglutide): Uses, Side Effects,

The safety and effectiveness of semaglutide tablets was evaluated in a 26-week clinical study that included 324 patients with moderate renal impairment (eGFR 30 to 59 mL/min/1.73 m2) [see Clinical Studies (14.1)]

Versatility in Treatment Options:Semaglutide's flexible dosing and administration make it a suitable option for a wide range of patients, whether they are looking primarily for weight management or need to control blood glucose levels due to diabetes

The main safety concern involves compounded GLP-1 medications, which lack FDA oversight for quality and consistency

These results show that semaglutide has greater efficacy than Contrave in managing weight loss

Brandon Richland, MD For individuals who cannot take semaglutide or prefer different options, several alternatives, both pharmaceutical and lifestyle-based, offer effective support for promoting weight loss